Insider / INSMED Inc
Adsett Roger
Chief Operating Officer at INSMED Inc
- Company
- INSMED Inc
- Ticker
- INSM
- First filing on record
- January 6, 2026
- Latest trade on record
- August 10, 2026
- SEC filings
- EDGAR ↗
Adsett Roger, Chief Operating Officer at INSMED Inc, has disclosed 20 transactions in INSM since January 6, 2026: 0 purchases (0 open-market buys) and 10 sales, worth about $54.4M at the reported prices. The latest was filed August 12, 2026, 2 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Adsett Roger made no purchases and 10 sales worth $48M, plus 10 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Adsett Roger has traded 1 stock on record; the largest by dollars is INSM.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 7 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 10 | 341,198 | $48.3M |
| M | Option exercise or conversion | 8 | 655,820 | $6.2M |
| A | Grant or award | 2 | 37,278 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 20 | 0 | 10 · $48.3M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| INSM | Option / conversion M | August 10, 2026 | August 12, 2026 | 2d | 80,970 | — | — | derivative | Form 4 ↗ | |
| INSM | Option / conversion M | August 10, 2026 | August 12, 2026 | 2d | 76,600 | — | — | derivative | Form 4 ↗ | |
| INSM | Option / conversion M | August 10, 2026 | August 12, 2026 | 2d | 82,280 | — | — | derivative | Form 4 ↗ | |
| INSM | Sell S | August 10, 2026 | August 12, 2026 | 2d | 239,850 | $133 | $32.0M | Form 4 ↗ | ||
| INSM | Option / conversion M | August 10, 2026 | August 12, 2026 | 2d | 80,970 | $30 | $2.5M | Form 4 ↗ | ||
| INSM | Option / conversion M | August 10, 2026 | August 12, 2026 | 2d | 76,600 | $17 | $1.3M | Form 4 ↗ | ||
| INSM | Option / conversion M | August 10, 2026 | August 12, 2026 | 2d | 82,280 | $14 | $1.1M | Form 4 ↗ | ||
| INSM | Sell S | June 3, 2026 | June 5, 2026 | 2d | 2,370 | $102 | $242K | Form 4 ↗ | ||
| INSM | Sell S | May 13, 2026 | May 15, 2026 | 2d | 5,837 | $116 | $678K | Form 4 ↗ | ||
| INSM | Option / conversion M | April 1, 2026 | April 3, 2026 | 2d | 88,060 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| INSM | Sell S | April 1, 2026 | April 3, 2026 | 2d | 62,344 | $165 | $10.3M | 10b5-1 plan | Form 4 ↗ | |
| INSM | Sell S | April 1, 2026 | April 3, 2026 | 2d | 19,001 | $164 | $3.1M | 10b5-1 plan | Form 4 ↗ | |
| INSM | Sell S | April 1, 2026 | April 3, 2026 | 2d | 6,715 | $163 | $1.1M | 10b5-1 plan | Form 4 ↗ | |
| INSM | Option / conversion M | April 1, 2026 | April 3, 2026 | 2d | 88,060 | $15 | $1.3M | 10b5-1 plan | Form 4 ↗ | |
| INSM | Sell S | February 3, 2026 | February 4, 2026 | 1d | 791 | $156 | $124K | Form 4 ↗ | ||
| INSM | Sell S | January 8, 2026 | January 8, 2026 | 0d | 2,059 | $174 | $359K | Form 4 ↗ | ||
| INSM | Sell S | January 7, 2026 | January 8, 2026 | 1d | 802 | $175 | $140K | Form 4 ↗ | ||
| INSM | Sell S | January 6, 2026 | January 8, 2026 | 2d | 1,429 | $173 | $248K | Form 4 ↗ | ||
| INSM | Other A | January 2, 2026 | January 6, 2026 | 4d | 31,280 | — | — | derivative | Form 4 ↗ | |
| INSM | Other A | January 2, 2026 | January 6, 2026 | 4d | 5,998 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 12, 2026 | Form 4 | 0001685904-26-000014 | 7 | published | EDGAR ↗ |
| June 5, 2026 | Form 4 | 0001685904-26-000012 | 1 | published | EDGAR ↗ |
| May 15, 2026 | Form 4 | 0001685904-26-000010 | 1 | published | EDGAR ↗ |
| April 3, 2026 | Form 4 | 0001685904-26-000008 | 5 | published | EDGAR ↗ |
| February 4, 2026 | Form 4 | 0001685904-26-000006 | 1 | published | EDGAR ↗ |
| January 8, 2026 | Form 4 | 0001685904-26-000004 | 3 | published | EDGAR ↗ |
| January 6, 2026 | Form 4 | 0001685904-26-000002 | 2 | published | EDGAR ↗ |
Other insiders at INSMED Inc
- Lewis William Chair and CEO 136 rows
- Flammer Martina M.D. Chief Medical Officer 67 rows
- Smith Michael Alexander Chief Legal Officer 30 rows
- Schaeffer Orlov S Nicole Chief People Strategy Officer 15 rows
- Bonstein Sara Chief Financial Officer 10 rows
- SHAROKY MELVIN MD Director 9 rows
- LEE LEO Director 6 rows
- Brennan David R Director 5 rows
- ANDERSON ELIZABETH M Director 3 rows
- Butera Samuele SVP, GM, Global Respiratory 2 rows
Everyone on file, with contracts and lobbying under the company's name: INSMED Inc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 7 | 20 | January 6, 2026 | August 12, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.